Kinetic analysis of neuroreceptor binding using PET

International Congress Series

Volumn 1265, Issue C, 2004, Pages 12-24

  Cunningham, Vincent J ^a   Rabiner, Eugenii A ^a   Matthews, Julian C ^a   Gunn, Roger N ^a   Zamuner, Stefano ^b   Gee, Antony D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GSK   (Italy)

Author keywords

Kinetic modeling; Neuroreceptor; Positron emission tomography

Indexed keywords

EID: 84861233689     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.03.024     Document Type: Article

References (19)

1. Mintun, M.A., et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 15 (1984), 217–227.
2. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J. Cereb. Blood Flow Metab. 11 (1991), 735–744.
3. Gunn, R.N., Gunn, S.R., Cunningham, V.J., Positron emission tomography compartmental models. J. Cereb. Blood Flow Metab. 21 (2001), 635–652.
4. Laruelle, M, Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 20 (2000), 423–451.
5. 11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171—PET studies in rhesus monkey. Neuropharmacology 39 (2000), 664–670.
6. Zamuner, S, Gomeni, R, Bye, A, Estimate the time varying brain receptor occupancy in PET imaging experiments using non-linear fixed and mixed effect modeling approach. Nucl. Med. Biol. 29 (2002), 115–123.
7. Crone, C, The permeability of capillaries in various organs as determined by the use of the ‘indicator diffusion’ method. Acta Physiol. Scand. 58 (1963), 103–113.
8. 11C]raclopride in anaesthetised rodents. Synapse 51 (2004), 206–212.
9. Inoue, O, Kobayashi, K, Gee, A, Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments. Crit. Rev. Neurobiol. 13 (1999), 199–225.
10. 3H]N-methylspiperone induced by oxotremorine. J. Neural Transm. 105 (1998), 1193–1197.
11. 123I]beta-CIT by MK-801 in rat brain. Synapse 30 (1998), 402–408.
12. Gunn, R.N., et al. Parametric imaging of ligand–receptor binding in PET using a simplified reference region model. NeuroImage 6 (1997), 279–287.
13. Turkheimer, F.E., Hinz, R, Cunningham, V.J., On the undecidability among kinetic models: from model selection to model averaging. J. Cereb. Blood Flow Metab. 23 (2003), 490–498.
14. Patlak, C.S., Blasberg, R.G., Fenstermacher, J.D., Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3 (1983), 1–7.
15. 11C-methyl]-(−)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10 (1990), 740–747.
16. Turkheimer, F.E., et al. Rank-shaping regularization of exponential spectral analysis for application to functional parametric mapping. Phys. Med. Biol. 48 (2003), 3819–3841.
17. Gunn, R.N., et al. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J. Cereb. Blood Flow Metab. 22 (2002), 1425–1439.
18. Cunningham, V.J., Jones, T, Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab. 13 (1993), 15–23.
19. Endres, C.J., et al. Simultaneous modeling of multiple brain time–activity curves with parameter coupling: applications using reference tissue models. J. Cereb. Blood Flow Metab., 23, 2004, 676.